ClinicalTrials.Veeva

Menu

Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging

U

University Hospital Essen

Status

Completed

Conditions

Lung Cancer With Mediastinal Lymph Node Involvement

Treatments

Other: No intervention

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01653002
11-4921-BO (Other Identifier)
RLK-Epi-1

Details and patient eligibility

About

A DNA hypermethylation of the gene locus SHOX2 can be frequently found in lung cancer tissue. The purpose of this study is to determine whether the assessment of the hypermethylation level of SHOX2 in specimens obtained by endosonographic guided bronchoscopy makes a contribution to lung cancer staging.

Enrollment

200 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of lung cancer
  • enlarged mediastinal or hilar lymph nodes (>10 mm)

Exclusion criteria

  • clinical condition which excludes general anesthesia

Trial design

200 participants in 1 patient group

Lung cancer with lymph node involvement
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems